Investor Israel Englander Increases Stake in Intuitive Surgical
Israel Englander has boosted his investment in Intuitive Surgical, reflecting his confidence in the company's prospects in the healthcare sector.
18 articles tagged with "Stocks"
Israel Englander has boosted his investment in Intuitive Surgical, reflecting his confidence in the company's prospects in the healthcare sector.
Prominent investor Israel Englander is increasing his investment in Norfolk Southern Corporation, drawing attention from the investment community.
Trump, on Easter, threatens 'hell' on Iran's infrastructure if Strait remains blocked Reuters
The stocks of major Medicare Advantage insurers surged on the announcement.
Strategic angle: A recent advancement in Google AI technology is impacting the stock performance of major memory chip manufacturers.
Energy prices are on the rise as the conflict in Iran escalates, according to CBS News.
Strategic angle: Wall Street analysts recommend strategies to navigate market downturns influenced by geopolitical tensions in Iran.
A deep dive into the potential of nuclear energy investments for the upcoming year.
Strategic angle: Meta's legal challenges and rising oil prices contribute to a significant decline in tech stocks.
Strategic angle: A comprehensive review of the top-performing Canadian mining stocks this week.
Strategic angle: Concerns over AI security lead to a decline in tech stocks.
Strategic angle: A comparison of two leading mining stocks to guide your investment decisions.
A comparison of two leading nuclear energy stocks, Cameco and Centrus Energy.
Strategic angle: An analysis of Citigroup Inc. as a potential long-term investment.
Strategic angle: Jim Cramer recommended buying IBM shares based on strong fundamentals, leading to a notable increase in stock value.
Strategic angle: Nuclear energy stocks are gaining traction with notable increases in Oklo and NuScale Power shares.
Strategic angle: A comparison of investment returns from two iconic brands over the past decade.
Strategic angle: BioNTech's stock takes a hit as cofounders announce their departure and the company's outlook fails to meet expectations.